Jm. Hevko et al., Synthesis of 5-oxo-6,8,11,14-eicosatetraenoic acid and identification of novel omega-oxidized metabolites in the mouse macrophage, J PHARM EXP, 296(2), 2001, pp. 293-305
Citations number
48
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
The metabolism of arachidonic acid by the 5-lipoxygenase pathway not only l
eads to the formation of leukotrienes but also to the biologically active e
icosanoid 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE). The synthesis
of 5-oxo-ETE was investigated in the elicited peritoneal macrophage and the
formation of 5-hydroxyeicosatetraenoic acid (5-HETE) as well as 5-oxo-ETE
was quantitated using stable isotope dilution tandem mass spectrometry. The
metabolism of 5-oxo-ETE in these same cells led to the formation of a seri
es of novel less lipophilic metabolites oxidized near the methyl terminus t
hat were structurally characterized using electrospray LC/MS and LC/MS/MS.
Five novel metabolites of 5-oxo-ETE were identified including 5,18-diHETE,
5,19-diHETE, 5-oxo-19-HETrE, 5-oxo-18-HETrE, and 5,19-diHETrE. These metabo
lites corresponded to omega -1 and omega -2 oxidation of 5-oxo-ETE presumab
ly formed by a specific cytochrome P450. There was no evidence for the form
ation of omega -oxidation (20-hydroxy metabolites), which are known product
s of metabolism of 5-oxo-ETE in other cell types. None of the metabolites w
ere found to elevate intracellular calcium release, suggesting that this me
tabolic pathway may result in inactivation of 5-oxo-ETE. This is the first
report of the biosynthesis of 5-oxo-ETE by tissue resident cell outside of
the blood and the formation of novel omega -1 and omega -2 oxidation of thi
s eicosanoid.